Is Weed Legal in Switzerland? Understanding Switzerland Cannabis and Marijuana Laws (2026)

Cannabis in Switzerland sits in three different legal categories at once. Medical cannabis is legal and available on prescription. Low-THC cannabis and CBD products are sold openly in shops. Recreational (non-medical) cannabis with more than 1% THC is still prohibited, although adults caught with small amounts face only a modest fine rather than a criminal record. At the same time, Switzerland is running one of Europe’s most extensive sets of government-supervised recreational cannabis trials and is drafting a national law that would legalise and regulate the adult market. This guide explains what is legal today, what the penalties are, and where the law is heading.

Is cannabis legal in Switzerland?

Cannabis is partly legal in Switzerland. Its status depends on the product and the purpose:

• Medical cannabis — legal on prescription since the law changed in 2022.
• CBD and low-THC cannabis (under 1% THC) — legal to produce, sell and buy.
• Recreational cannabis (1% THC or more) — still prohibited, but possessing up to 10 grams for personal use is not a criminal offence, and adult consumption is treated as a minor infraction.
• Regulated adult sales — currently allowed only for registered participants in official scientific pilot trials in several cities.

Cannabis remains classified as a controlled narcotic under the federal Narcotics Act, so the default rule is that growing, importing, producing and selling it is banned unless a specific exception applies. Switzerland’s drug policy is built on a long-standing “four-pillar” model of prevention, therapy, harm reduction and enforcement, and its current cannabis reforms are framed around public health rather than commercial liberalisation. Cannabis is still the most widely used illegal substance in the country: federal health authorities estimate that around 220,000 people use it regularly for non-medical purposes, a figure that has held steady at a high level for years alongside a substantial illicit market.

Is medical cannabis legal in Switzerland?

Yes. Medical cannabis is legal and can be prescribed by a doctor and dispensed through pharmacies. The decisive change came on 1 August 2022, when an amendment to the Narcotics Act removed the requirement for patients to obtain a special exceptional licence from the Federal Office of Public Health (FOPH) for each prescription. Before that date, every medical-cannabis prescription needed individual federal authorisation, which made access slow and bureaucratic.

Under the current rules, doctors decide on treatment directly with their patients, and the choice of whether to prescribe cannabis-based medicines rests with the treating physician. The reform also allowed Swiss companies to cultivate and export medical cannabis for commercial purposes, provided they hold the necessary licence from Swissmedic, the national authority for therapeutic products. To build the evidence base, the FOPH collects pseudonymised data on medical-cannabis treatments through to 2029.

Medical cannabis is typically considered for symptoms such as chronic pain, muscle spasticity and treatment-related nausea or weight loss, usually when standard treatments have not worked or as a complementary therapy. A federal health technology assessment found the evidence on efficacy for chronic pain and muscle spasms to be limited and associated with higher costs, which is one reason coverage and prescribing remain carefully managed.

Is recreational cannabis legal in Switzerland?

No. Recreational cannabis containing 1% THC or more is illegal in Switzerland for the general public. Growing, importing, producing and selling it is prohibited, and the only place adults can legally buy regulated cannabis for non-medical use is inside an authorised scientific pilot trial. The FOPH is explicit that, outside those trials, the ban on cannabis remains fully in force.

What sets Switzerland apart is that it has chosen to test regulated access through controlled experiments rather than leaving the question to the illicit market alone. Those trials, described in more detail below, are designed to produce hard data for the national legalisation bill now moving through parliament.

What are the penalties for cannabis in Switzerland?

Penalties scale with the amount and the activity. Possession of up to 10 grams of cannabis for personal use is not a criminal offence: the law has treated this “negligible quantity” as non-punishable since the rule took effect on 1 October 2013. Adults caught actually consuming cannabis can be handed a fixed penalty of 100 Swiss francs, which is paid like a traffic ticket and carries no criminal record.

Beyond personal use, the picture changes sharply. Dealing, cultivation, or possession of larger quantities is a criminal offence that can carry a custodial sentence of up to three years or a monetary penalty, with tougher minimum sentences for aggravated cases such as trafficking that endangers many people or generates large profits. Supplying cannabis to anyone under 18 is a separate offence. Driving under the influence is treated strictly, with a zero-tolerance approach to THC behind the wheel.

Is CBD legal in Switzerland?

Yes. CBD is legal in Switzerland, and the country has one of Europe’s more permissive frameworks for it. The key is the THC threshold: cannabis products containing less than 1% THC fall outside the scope of the Narcotics Act, so CBD flower, oils and other formulations can be produced and sold legally. CBD products are widely available in tobacco shops, kiosks and dedicated stores.

Legality still depends on the product category. A CBD oil, food supplement, cosmetic or vape must each comply with the ordinary Swiss rules governing that type of product — foodstuffs, cosmetics, chemicals or therapeutic-products law — and Swiss regulators publish joint guidance clarifying how cannabidiol products are classified and what standards each category must meet. Switzerland’s 1% THC ceiling is notably higher than the European Union’s, where regulators continue to wrestle with cannabinoid policy; the EU is even weighing a contested move to reclassify CBD in cosmetics, a debate Switzerland is not bound by because it is not an EU member.

Is hemp legal in Switzerland?

Yes. Industrial and low-THC hemp is legal in Switzerland. Because the dividing line for a controlled narcotic is set at 1% THC, hemp and “cannabis light” products below that level can be grown and marketed without falling under narcotics control. This is a more generous limit than the 0.3% THC ceiling the European Union applies to industrial hemp.

That gap matters for businesses and travellers alike, because a hemp or CBD product that is perfectly legal in Switzerland may not be legal across the border. Several EU member states are tightening their own rules — Greece, for example, has moved to ban retail sales of hemp flower despite warnings of conflict with EU law — so the Swiss threshold should not be assumed to carry over elsewhere.

Switzerland’s recreational cannabis pilot trials

Switzerland is testing regulated recreational sales through a series of scientific pilot trials that let registered adult residents buy quality-controlled cannabis legally. The legal basis was created when an amendment to the Narcotics Act took effect on 15 May 2021, adding a provision (Article 8a) that lets the FOPH authorise time-limited, locally restricted trials for a maximum of ten years. The trials are strictly regulated: products are tracked from seed to sale, advertising is banned, minors are excluded, and staff provide health information and advice at the point of sale.

There are now eight authorised pilot trials running across the country, testing different distribution models — pharmacies, non-profit outlets, more commercial shops, cannabis social clubs and, most recently, online sales with home delivery:

• WeedCare — Basel-Stadt, the first trial to begin dispensing, in January 2023, through pharmacies.
• Züri Can — the City of Zurich’s trial, the largest in the country.
• SCRIPT — Bern, Biel and Lucerne, focused on non-profit pharmacy sales with advice.
• Cann-L — the City of Lausanne.
• La Cannabinothèque — Vernier, in the canton of Geneva.
• Grashaus Projects — Liestal and Allschwil, in Basel-Landschaft.
• Cannabis Research Zürich — a separate, larger study in the canton of Zurich.
• CanLeg — the canton of St. Gallen, launched in 2026 and run by ETH Zurich and the University of Zurich; it is the first trial to test online ordering with home delivery.

The latest overarching evaluation of the trials, published in January 2026 by the University of Lausanne and the University of Applied Sciences and Arts Northwestern Switzerland, drew on roughly 10,500 participants across the projects. Its early findings are striking: legal sales were well received, consumption did not rise despite easier access, and there was a measurable shift toward lower-risk use such as vaping, edibles and lower-THC products. The report found no negative impact on participants’ physical or mental health, and trials price higher-THC products more steeply to nudge consumers toward safer choices. The detailed design of the WeedCare study in Basel — a randomised, controlled comparison between regulated pharmacy purchases and the black market — illustrates how rigorously these projects are being run.

Will Switzerland fully legalise cannabis?

Switzerland is actively drafting a national law to legalise and regulate adult cannabis, but it is not law yet and remains several years away. The vehicle is a proposed Cannabis Products Act (Cannabisproduktegesetz, or CanPG), which implements a parliamentary initiative — filed by then-National Councillor Heinz Siegenthaler — that both chambers’ health committees backed in 2021. A subcommittee drafted the bill, and the National Council’s Social Security and Health Committee adopted the preliminary draft in February 2025.

The committee then opened a public consultation that ran from 29 August to 1 December 2025, publishing the full draft for comment for the first time. The responses were substantial and divided, and on 7 May 2026 the committee sent the draft back to its subcommittee for revision so that the many proposed amendments could be worked in before a parliamentary vote. That referral pushed the timetable out further; the existing pilot trials are being extended while the legislative work continues.

As drafted, the bill keeps cannabis classified as a narcotic but lifts the blanket ban for adults, allowing them to buy, possess and consume cannabis and to grow a small number of plants at home. Sales would run only through a limited number of licensed outlets — plus a single federally licensed online channel — on a non-profit basis, with no advertising, neutral and child-resistant packaging carrying warnings, and a steering levy that makes higher-THC products more expensive. The model is deliberately health-focused, and the cantons would handle much of the enforcement. Because any final law could still be challenged at the ballot box through Switzerland’s referendum system, a national legal market is unlikely to open for several years. For context on how Switzerland fits into the wider continent’s shifting rules, see our overview of Europe’s cannabis markets and the broader global legalisation landscape.

Can tourists buy or use cannabis in Switzerland?

Tourists cannot legally buy recreational cannabis in Switzerland. The pilot-trial programmes that allow regulated sales are limited to registered adult residents of the participating cities, so visitors are not eligible to take part. What travellers can legally buy are CBD and low-THC products (under 1% THC), which are sold openly in shops across the country.

Visitors should also be careful about borders. Because Switzerland’s low-THC threshold is more generous than its neighbours’, a product bought legally in a Swiss shop can be illegal to carry into France, Germany, Italy or Austria. Anyone considering a trip built around cannabis should research local rules first; our guide to cannabis tourism covers how quickly destination rules are changing. The safe assumption in Switzerland is that anything over 1% THC is off-limits for non-residents, while small-quantity personal possession is decriminalised rather than legal.

The bottom line on cannabis in Switzerland

Switzerland offers legal medical cannabis, a permissive CBD and low-THC market, and decriminalised personal possession, while full recreational legalisation is still being built rather than enacted. The country’s evidence-first approach — large, government-run pilot trials feeding directly into a draft national law — has made it one of the most closely watched cannabis-policy stories in Europe. For now, the practical rules are clear: get a prescription for medical use, stay under the 1% THC line for anything bought off the shelf, and keep personal amounts small. Whether Switzerland becomes the first country in continental Europe to open a fully regulated adult market will depend on how the Cannabis Products Act fares in parliament and, quite possibly, at a national referendum.